Live from the NIH registry
Studies recruiting near Salt Lake City right now
Top 25 of 1,184 recruiting studies, sorted by proximity — each links to its official registry page
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Pennsylvania
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Primary Children's Hospital — Salt Lake City, Utah (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
Emergency Contraception
Phase 4
Interventional 790 participants sought
Planned Parenthood Association of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Lori Gawron
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Huntsman Cancer Hospital at the University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Hoffmann-La Roche
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Salt Lake City, Utah (2.4 mi)
· Sponsor: Sameek Roychowdhury
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Salt Lake City, UT — Salt Lake City, Utah (2.4 mi)
· Sponsor: Mediar Therapeutics
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
University of Utah Hospitals & Clinics — Salt Lake City, Utah (2.4 mi)
· Sponsor: Genentech, Inc.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Intermountain Healthcare — Salt Lake City, Utah (2.4 mi)
· Sponsor: Lyell Immunopharma, Inc.
Massage: Neuroimaging and Correlates of Response - 6-week Study
Healthy Control
N/A
Interventional 46 participants sought
Huntsman Mental Health Institute — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
Local Institution - 0158 — Salt Lake City, Utah (2.4 mi)
· Sponsor: Bristol-Myers Squibb
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
NETs: Protection or Harm in Neonatal Inflammation or Infection
Necrotizing Enterocolitis (NEC)
N/A
Observational 388 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Utah Cancer Specialists (site 203) — Salt Lake City, Utah (2.4 mi)
· Sponsor: VM Oncology, LLC
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Utah Cancer Specialists-Salt Lake City — Salt Lake City, Utah (2.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Associates of Utah, PLLC — Salt Lake City, Utah (2.4 mi)
· Sponsor: Genentech, Inc.
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Delirium, Neurocognitive Disorders
N/A
Interventional 1,900 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Michigan
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10305, Layton, UT — Layton, Utah (19.6 mi)
· Sponsor: Colorado Prevention Center
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Highland Clinical Research /ID# 270281 — Salt Lake City, Utah (2.4 mi)
· Sponsor: AbbVie
Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings
Epilepsy, Autobiographical Memory
N/A
Interventional 50 participants sought
Clinical Neurosciences Center, University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Salt Lake City, Utah (2.4 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase 3
Interventional 117 participants sought
Eccles Primary Children's Outpatient Services - Cardiology — Salt Lake City, Utah (2.4 mi)
· Sponsor: Bayer
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Sepsis, Acute Kidney Injury
Phase 2
Interventional 124 participants sought
Research Site — Salt Lake City, Utah (2.4 mi)
· Sponsor: AstraZeneca
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
Adult Cystic Fibrosis Center at the University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Anagram Therapeutics, Inc.
Clinical Decision Support Tool in PARDS Pilot Study
Ventilation Therapy; Complications, Ventilator-Induced Lung Injury
N/A
Interventional 180 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Children's Hospital Los Angeles
Precision Genomics Medicine Biobank
Any Disease Condition and Reportedly-healthy Subjects
N/A
Observational 100,000 participants sought
Intermountain Healthcare — Murray, Utah (8.0 mi)
· Sponsor: Intermountain Health Care, Inc.